Evidence map›Paper›PMID 35080115›Full record

ArticleJournal of biomedical materials research. Part A2022

Sustained released of bioactive mesenchymal stromal cell-derived extracellular vesicles from 3D-printed gelatin methacrylate hydrogels.

Louis J Born, Shannon T McLoughlin, Dipankar Dutta, Bhushan Mahadik, Xiaofeng Jia, John P Fisher, Steven M Jay

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Exosomes derived from CD271Theranostics · 2024
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Louis J BornFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Shannon T McLoughlinFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Dipankar DuttaFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Bhushan MahadikFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Xiaofeng JiaDepartment of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
John P FisherFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
Steven M JayFischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.

Funding

Training and Dissemination CoreP41EB023833 · NIBIB · UNIV OF MARYLAND, COLLEGE PARK · PI FISHER, JOHN P · 2017 to 2021
$6.2M
Controlling Exosome Noncoding RNA Cargo for Enhanced Wound HealingR01HL141611 · NHLBI · UNIV OF MARYLAND, COLLEGE PARK · PI JAY, STEVEN MICHAEL · 2018 to 2022
$1.9M
National Science Foundation 1750542NHLBI NIH HHS R01 HL141611NIBIB NIH HHS P41 EB023833NIH HHS HL141611NIH HHS P41EB023833
6 · The paper itself

Abstract

Extracellular vesicles (EVs) represent an emerging class of therapeutics with significant potential and broad applicability. However, a general limitation is their rapid clearance after administration. Thus, methods to enable sustained EV release are of great potential value. Here, we demonstrate that EVs from mesenchymal stem/stromal cells (MSCs) can be incorporated into 3D-printed gelatin methacrylate (GelMA) hydrogel bioink, and that the initial burst release of EVs can be reduced by increasing the concentration of crosslinker during gelation. Further, the data show that MSC EV bioactivity in an endothelial gap closure assay is retained after the 3D printing and photocrosslinking processes. Our group previously showed that MSC EV bioactivity in this assay correlates with pro-angiogenic bioactivity in vivo, thus these results indicate the therapeutic potential of MSC EV-laden GelMA bioinks.

Indexed as

Extracellular VesiclesMesenchymal Stem CellsGelatinHydrogelsMethacrylatesPrinting, Three-DimensionalGelatinHydrogelsMethacrylates3D printingexosomesGelMAMSCs

Identifiers

PMID35080115
PMCPMC11570911

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.